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Summary.-Lymph node and peripheral blood lymphocytes were studied simul-
taneously for surface markers of T and B cells in22 patients with lymphoproliferative
diseases and 8 patients with non-neoplastic lymphadenopathy. This resulted in
the classification of the malignancy from involved lymph nodes into 4 groups. Six
patients had B cell lymphomata with normal or strong immunofluorescent staining
for surface membrane immunoglobulin; 8 patients had B cell chronic lymphocytic
leukaemia with pale staining for surface membrane immunoglobulin; 5 patients had
T cell lymphomata and 3 patients were not definitely classifiable.
In 6 out of 8 patients with B cell CLL, histopathology of lymph nodes showed
infiltration with well differentiated lymphocytes and in all T cell lymphomata, the
infiltrating cells were poorly differentiated.
By the use of these markers, malignant lymphocytes were identified in the cir-
culation in only 3 out of 6 patients with B cell lymphoma, in all patients with B cell
CLL but in none of those withT cell lymphoma orunclassifiablelymphoma. There-
fore a more conclusive characterization of the malignant lymphocyte in lymphoproli-
ferative diseases must include an examination of involved lymph nodes.
THE RECOGNITION of surface markers
on T and B cells has permitted an addi-
tional classification of lymphoproliferative
disease into malignancies of T or B cell
origin (Hansen and Good, 1974). The
malignant lymphocyte in most patients
with chronic lymphocytic leukaemia (CLL)
has been shown to be of monoclonal B cell
origin (Seligmann, Preud'Homme and Bro-
uet, 1973). By the study of peripheral
blood, the B cell origin of the malignant
lymphocyte from a minority of patients
with non-Hodgkin's lymphoma has also
been confirmed (Aisenberg and Bloch,
1972; Gajl-Peczalska et al., 1973; Piessens
et al., 1973). A small number of patients
with lymphoproliferative disease of T cell
origin has been described (Seligmann et al.,
1973; Smith et al., 1973; Yodoi et al.,
1974).
Examination of peripheral blood in
many patients with lymphoproliferative
disease does not allow the identification of
the malignant lymphocyte because suffi-
cient numbers of such cells may not be
circulating. The spectrum of lympho-
proliferative disease includes patients with
high peripheral blood lymphocyte counts
classified as CLL and those with relatively
normal counts and large tumour masses
referred to as lymphocytic lymphoma
(LL), but there exists an intermediate
group with modestly raised counts and
tumour mass which is difficult to classify.
There have been few studies of malig-
nant lymphocyte surface markers in the
main lymphoid organs (lymph nodes and
spleen) where the bulk of tumour occurs
(Jaffe et al., 1974; Peter, Mackenzie and
Glassy, 1974). For this reason the present
study was undertaken in an attempt to
classify the neoplasms into T or B cell type
by examination of surface markers of
lymphocytes in the histopathologically
involved lymph nodes. Attempts were
also made to correlate these immuno-T AND B CELL POPULATIONS IN BLOOD AND LYMPH NODE
logical findings with the morphological
findings in the involved lymph nodes
and to see if the intermediate group of
patients with lymphoproliferative disord-
ers, referred to above, could be further
categorized.
MATERIALS AND METHODS
Patients-Twenty-two patients with vari-
otIs lymphoproliferative disorders and 8
patients with non-neoplastic lymphadeno-
pathy wNere studied by simultaneous examina-
tion of peripheral blood and surgically
removed lymph nodes. The diagnoses were
LL (14 patients), CLL (7), Waldenstroin's
macroglobulinaemia (1), recent viral infec-
tion (4), incidental lymph nodes removed at
surgery (2), dermatopathic lymphadeno-
pathy (1) and anaerobic diphtheroid infec-
tion (1). The distinction between LL and
CLL was made on the basis of peripheral
blood lymphocyte count and lymph node
tumour mass, a relatively normal lymphocyte
count (in untreated patients) with large
lymph node masses favouring the cliniical
diagnosis of LL. Of the 22 patients with
lymphoproliferative disorders, 8 had been
previously treated with corticosteroids, alky-
lating agents and/or radiotherapy.
Controls.-Peripheral blood from 78 adult
hospital and laboratory staff was used to
establish a normal range.
Histopathology.-The excised lymph nodes
were cut, one portion being processed for
routine histopathology, the other for immuno-
logical testing. Those patients with malig-
nant lymphoma were classified according to
Rappaport (1966). The results reported in
this study of patients with lymphoprolifera-
tive disease are derived only from those with
lymph nodes which were shown to have the
architectural changes diagnostic of malig-
nant lymphoma.
Lymphocyte counts-Total white cell
counts were obtained using a Coulter S
automated counter. Differentials were per-
formed on 200 wlhite cells in stained films.
Lymphocyte isolation.-The portions of
lymph nodes for immunological study were
gently teased with fine forceps in calcium and
magnesium-free Dulbecco phosphate buffered
saline (PBS) (Commonwealth Serum Labora-
tories, C.S.L., Melbourne, Australia). The
resulting cell suspension was placed on
Ficoll- (Pharmacia, Sydney, Australia),
Hypaque (Winthrop, Sydney, Australia)
gradients according to the method of Boyum
(1968) and the mononuclear cells collected
and washed 3 times with PBS. Peripheral
blood mononuclear cells were similarly iso-
lated. Mononuclear cell preparations were
at least 9000 viable by trypan blue exclusion.
E rosette forming lymphocytes (E-RFL).
T cells were determined by non-immune
rosette formation (Special Technical Report,
1974). Fresh sheep red blood cells (SRBC) in
Alsever's solution (C.S.L., Melbourne) wvere
washed 3 times in PBS. 5 x 105 lympho-
cytes were resuspended in 50 ,ul of calcium
and magnesium-free Hanks' phosphate buf-
fered saline (C.S.L., Melbourne) to which was
added 50 ,A foetal calf serum (C.S.L., Mel-
bourne) heat inactivated and adsorbed with
SRBC, followed by 50 IA of 0-500 suspension
of SRBC. This mixture was incubated at
37TC for 5 min, spun at 200 g for 5 min, incu-
bated at 4TC overnight, resuspended by 10
gentle pipettings up and down and counted in
a haemacytometer chamber. Lymphocytes
with 4 or more SRBC rosetting were counted
as positive.
EA rosetteforming lymphocytes (EA-RFL).
SRBC sensitized with rabbit antibody were
used to identify the Fc receptor on B cells
(Shevach, Jaffe and Green, 1973; Froland
and Natvig, 1973). A 0-500 suspension of 3
times washed SRBC was incubated in 4 ml
of a 1 in 200 dilution of rabbit anti-SRBC
antiserum (Wellcome Diagnostics, Sydney,
Australia) for 30 min at 37TC. The sensi-
tized cells were washed 3 times in PBS and
made up to a 0-500 suspension in Hanks'
buffer solution. Equal 50 pA volumes of
lymphocytes, foetal calf serum and sensitized
SRBC were incubated together for 5 min at
37TC, spun at 200 g for 5 min and incubated
overnight at 4°C. The mixture was vigor-
ouslv resuspended on a vortex mixer to break
up any E-RFL and the EA-RFL were
counted. Lymphocytes with 4 or more
SRBC rosetting were counted as positive.
Monocytes were excluded on inorphological
grounds.
Surface membrane immunoglobulin (S,n4g)
staining.-Solid phase adsorbed sheep anti-
sera to human IgG, IgA and IgM were
obtained commercially from Wellcome Diag-
nostics, Sydney, Australia. Specificity of
batches was checked by Ouchterlony, immu-
noelectrophoresis and by immunofluorescent
(IF) staining of myeloma and macroglobulin-
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aemia cells in smears. All aintisera used were
monospecific by these criteria. The antisera
were fluorescein conjugated (fluorochrome-
protein ratio of 3: 1) by the method of
Yamamoto and Kawamura (1970) and were
centrifuged at high speed for 10 min just
before use to remove possible aggregates.
Three times PBS washed lymphocytes w%Aere
mixed with a previously determined optimal
dilution of conjugated antiserum for 30 min
at 4°C. The mixture was washed 3 times
with cold PBS and one drop of glycerol wras
added to the pellet. At least 200 cells in
suspension were counted using a Reich-ert
Zetopan fluorescence microscope equipped
with epi-illumination, SP3 mercury vapour
lamp and 63 times immersion objective.
Cells wvere first identified as lymphocytes
under phase contrast. Intensity of staining
was described as pale, normal or strong com-
pared wxvith control lymphocytes.
Phytohaemagglutinin (PHA) response.
This was performed according to a technique
previously described (Ziegler, Hansen and
Penny, 1975) w%ith slight modifications.
Briefly, lymphocytes were obtained from the
Ficoll-Hypaque gradients and washed 3
times. The cell suspension wAas diluted in
medium 199 (C.S.L., Melbourne) containing
20% autologous serum to give a final con-
centration of 5 x 105 lymphocytes/ml. PHA
(MR 10, Welleome Diagnostics, Sydney) was
added to duplicate 1 ml cultures to give
concentrations of 0, 10, 100 and 200 ,ug/ml.
The cultures were incubated for 68 h and
pulsed with 2 ,uCi of 6-3H thymidine (Radio-
chemical Centre, Amersham, U.K.), specific
activity 24-6 Ci/mmol, for the last 2 h. The
radioactivity incorporated into DNA Awas
determined by liquid scintillation counting.
During the course of this study a micro-
method using 105 lymphocytes cultured in
disposable sterile microtitre plates (Linbro,
Microbiological Associates, Bethesda, U.S.A.)
was set up. The cells were harvested on to
glass fibre filter discs (Reeve-Angel, AMicro-
biological Associates, Bethesda) using a
multiple automated sample harvester (MASH
II, Microbiological Associates, Bethesda).
The other aspects of the micromethod were
as described for the macromethod above but
scaled downi 5 times. Comparable dose-
response curves were obtained in siinul-
taneously studied patients and controls. No
patient's cells w%Nere set up without the corres-
ponding normal macro or micro control.
PHA response of lymphocytes from lymph
node anid blood was classified as normal,
moderately reduced or severely reduced,
depending on the degree of depressioii of the
PHA dose-response curve compared with
normals. A moderately reduced PHA dose-
response curve wNas reduced at lowr doses
(10 pg/ml) of PHA but recovering to normal
or near normal at optimal doses (100, 200
Mug/ml). A severely reduced PHA dose
response curve w-as markedly reduced at all
doses of PHA.
RESULTS
The results of determinationis of T and
B cell markers in 78 controls and 8
patients with nonspecific lymphadeno-
pathy are presented in Table I. In
patients with non-neoplastic lymphadeno-
pathy, 2 out of 3 patients with a high
percentage of E-RFL in lymph nodes had
recent infectious mononucleosis. PHA
responsiveness was normal in all of these
patients except one who had recent cyto-
mnegalovirus infection. Histopathology of
the lymph nodes in all of these patients
showed changes of reactive hyperplasia.
On the basis of the numbers an(d
pattern of markers of T and B cells in the
peripheral blood and lymph nodes of these
patients with lymphoproliferative dis-
eases, it was possible to classify them into
4 groups. The results of the first group
of 6 patients, regarded as B cell lymph-
oma, are shown in Table II. The lymph
nodz lymphocytes of these patients were
characterized by reduced percentages of
E-RFL, moderately reduced PHA res-
ponsiveness in 4 and severely reduced in 2,
normal or slightly raised percentages of
EA-RFL an(d more than 50°% lympho-
cytes with normal or strong IF staining
for Sm,u in 5 and Smy in one. The peri-
pheral blood of these patients was charac-
terized by normal percentages of E-RFL
moderately reduced PHA responsiveness
in one, raised percentage of EA-RFL in
one and lymphocyteswith normal orstrong
IF staining for Sm,u in 2 and Smy in one.
Because of the similarity of IF staining
pattern of these lymphocytes to that of
the corresponding lymph node and theT AND B CELL POPULATIONS IN BLOOD AND LYMPH NODE
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increased numbers of these cells found
circulating, they are regarded as circulat-
ing lymphoma cells. Of the 3 patients
with circulating lymphoma cells, 2 were
untreated and had a modest peripheral
blood lymphocytosis. There was no con-
sistent histopathological abnormality in
this group.
The second group consisted of 8
patients who had B cell CLL and whose
results are illustrated in Table III. The
lymph nodes of these patients had re-
duced percentages of E-RFL, severely
reduced PHA responsiveness in 5, in-
creased percentages of EA-RFL in 2 and
lymphocytes with pale IF staining for
SmIg in 6. One patient had no cells
staining for SmIg in his lymph node. The
peripheral blood of these patients was
characterized byraisedlymphocyte counts,
reduced percentages of E-RFL and re-
duced PHA responsiveness in 7.
Although the EA-RFL reported in con-
trols was surrounded by 4 or more
sensitized SRBC, the lymphocytes in this
group characteristically rosetted in the
main only 2 SRBC. The percentage of
such peripheral blood EA-RFL was raised
in 7 of this group. All but one patient
had cells which were pale staining for
SmIg by IF. It was characteristic for
these patients to have a higher percentage
of EA-RFL in the peripheral blood than
in the lymph nodes. The lymph node
histopathology in 6 patients showed
replacement by welldifferentiated lympho-
cytes.
The third group comprised 5 patients
regarded as T cell lymphoma and the
results are shown in Table IV. The
lymph node was characterized by greater
than 5500 of E-RFL, severely reduced
PHA responsiveness in 2 of 3 tested and
EA-RFL were slightly raised in 2. There
was no particular abnormality in lym-
phocyte staining for SmIg. The peri-
pheral blood had a normal percentage of
E-RFL, moderately reduced PHA res-
ponsiveness in 2 and slightly increased
cells staining normally for SmIg in 3
patients. The consistent histopathologi-
cal abnormality in this group of patients
was infiltration of lymph nodes with
poorly differentiated cells.
The fourth group consisted of 3
patients whose lymphoma was unclassi-
fiable and the results are shown in Table
IV. The lymph nodes of these 3 patients
had reduced percentages of E-RFL, sev-
erely reduced PHA responsiveness in 2
and less than 20% of the cells stained
palely for Sm,u only, y and a being totally
negative. The peripheral blood showed
no specific features other than a reduced
percentage of E-RFL in 2.
DISCUSSION
By studying the lymphocytes in the
lymph nodes of 22 patients with lympho-
proliferative disorders for surface markers
on T and B cells, it has been possible to
classify these diseases into 4 distinct
groups: B cell lymphomata (6 patients),
B cell CLL (8), T cell lymphomata (5) and
unclassifiable lymphomata (3). Eleven
patients could have been classified by
examination of peripheral blood alone-
B cell lymphoma (3), B cell CLL (8). In
3 patients the origin of the malignant cell
was uncertain from examination of both
tissues. These findings are in agreement
with other series (Gajl-Peezalska et al.,
1973; Piessens et al., 1973) of non-
Hodgkin's lymphoma, where only one-
third of the patients were classified as
B cell lymphoma by examination of
peripheral blood alone. It can be seen
that the yield of positive classifications
approaches 80% if lymph node lympho-
cytes are studied, which is in agreement
with the findings of Aisenberg and Bloch
(1972); Seligmann et al. (1973); Huber et
al. (1974) and Peter et al. (1974). It is
possible that 2 patients studied after
treatment of B cell lymphoma may have
manifested circulating lymphoma cells
before commencement of therapy.
It has been reported that intensity of
staining by IF (Seligmann et al., 1973) or
by autoradiography (Wilson and Hurdle,
1973; Huber et al., 1974) is a good indi-
cator of the type of B cell proliferation.556 D. A. COOPER, V. PETTS, E. LUCKHURST, J. C. BIGGS AND R. PENNY
This is confirmed in this series where
normal or strong staining for SmIg by IF
was characteristic of relatively normal
peripheral blood lymphocyte counts and
large tumour mass, the type of disease
classified as LL. B cell CLL is character-
ized by high peripheral blood lymphocyte
counts and pale or absent staining for
SmIg. It was possible to classify 4
intermediate group patients with lympho-
cyte counts between 60001,ul and 10,000/,i
as CLL in 2 on the basis of pale staining
for SmIg in peripheral blood and lymph
node, and as LL in 2 with normal or strong
staining for SmIg in blood and lymph
node. It is possible that pale surface
staining is another manifestation of the
surface membrane abnormality in CLL
which has been suggested to explain other
findings of impaired recirculation and cap
formation (Flad et al., 1973).
Owing to our lack ofmonospecific light
chain antisera, the previously reported
monoclonal nature (Seligmann et al., 1973)
of the malignant lymphocyte in B cell
lymphoma and B cell CLL could not be
confirmed. Although the heavy chain
antisera were checked for specificity in the
conventional ways, these methods may
not guarantee monospecificity as has been
recently suggested (Special Technical Re-
port, 1974). This problem may have
resulted in many B cell CLL patients in
this series staining with antisera to more
than one heavy chain class. It was
possible to classify these lymphoprolifera-
tions with certain commercially available
antisera, an advantage for the non-
research laboratory.
It has been suggested that the malig-
nant lymphocyte may not display normal
surface markers (Seligmann et al., 1973;
Hansen and Good, 1974). Such phenom-
ena may explain several anomalies in this
study. Firstly, the patients with B cell
lymphomata had relatively decreased per-
centages of EA-RFL, which may reflect
an abnormal balance between SmIg and
the Fe receptor in these lymphocytes.
Secondly, many ofthe patients with B cell
CLL had increased numbers ofFc receptor
positive cells identified as EA-RFL, many
ofwhich had less than the defined number
of SRBC surrounding the lymphocyte
(Table III). This may reflect a low
affinity Fc receptor or decreased density of
Fc receptors on the malignant cell.
Thirdly, it has been shown that a malig-
nant cell may display both T and B cell
markers (Shevach et al., 1973; Brouet and
Prieur, 1974). This could explain the
increased percentage of EA-RFL in the
lymph nodes of 2 patients with T cell
lymphoma. Lastly, in 3 patients with
unclassifiable lymphoma, it might have
been possible to classify this group ifother
surface markers had been identified such
as the C3 receptor ofB lymphocytes or by
anti T or B cell antisera. However, the
malignant lymphocyte may lose surface
markers found on a normal cell and this
may prevent the identification of a small
percentage of lymphomata. One of these
3 patients was a 12-year-old boy with
massive acute mediastinal lymphadeno-
pathy, diagnosed as a Sternberg sarcoma.
In distinction to the patient of Smith et al.
(1973), who had a T cell lymphoma, T cell
origin in this patient is less likely because
of a low percentage of E-RFL.
The identification of 5 out of 14
lymphomata as T cellinorigininthisseries,
emphasizes the importance of examina-
tion of the lymph nodes in view of the
rarely reported occurrence of T cell
lymphoproliferative disease (Seligmann
et al., 1973; Smith et al., 1973; Yodoi et al.,
1974). The lymph node T cell percentage
in this group was not always greater than
70%, as emphasized by Peter et al. (1974)
but this may be explained by our stricter
criterion of 4 SRBC for a positive E-RFL.
A higher T cell percentage may have been
reached had only 3 SRBC been taken for a
positive E-RFL. These patients all had
poorly differentiated cells on histopath-
ology, which may have been the explana-
tion for severely reduced PHA responsive-
ness in 2 of 3 patients tested in this group.
Nodular lymphoma has been previously
shown to be of B cell origin (Jaffe et al.,
1974) but in one patient in the series ofT AND B CELL POPULATIONS IN BLOOD AND LYMPH NODE 557
Peter et al. (1974) and one in this series, a
nodular lymphoma of T cell origin is
described. It would be more definitive to
study such nodular lymphomata in tissue
sections if a good T cell marker for use in
such sections were available.
Three of 22 patients with lympho-
proliferative disorderswho cameto splenec-
tomy had nodular replacement of the
spleen by lymphoma. Splenic mono-
nuclear cells obtained in a similar maimLer
to lymph node cells were studied but a
corresponding classification of T or B cell
origin was not possible due to the un-
avoidable contamination of the nodules
with perinodular red pulp mononuclear
cells. Two of 3 patients with non-
neoplastic lymphadenopathy and high T
cell percentages in the lymph node had
recent infectious mononucleosis. The cir-
culating atypical lymphocyte in this
disease has been shown to be of a T-cell
origin (Sheldon et al., 1973) and these
findings support this observation.
Towards the latter part of this study
some patients with lymphadenopathy
could be confidently and easily dia,gnosed
on the day of lymph node biopsy by
examination of T and B cell populations
in the lymph nodes, a possible advantage
when routine histopathology often takes
several days for processing. Finally, this
classification may be important for diag-
nosis, defining prognosis and response
to treatment and in understanding the
pathophysiology of the lymphocyte in
lymphoproliferative disease.
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